Ann E. Lloyd

628 total citations
7 papers, 485 citations indexed

About

Ann E. Lloyd is a scholar working on Epidemiology, Cardiology and Cardiovascular Medicine and Applied Microbiology and Biotechnology. According to data from OpenAlex, Ann E. Lloyd has authored 7 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Epidemiology, 2 papers in Cardiology and Cardiovascular Medicine and 2 papers in Applied Microbiology and Biotechnology. Recurrent topics in Ann E. Lloyd's work include Antibiotic Use and Resistance (2 papers), Urinary Tract Infections Management (1 paper) and Parasite Biology and Host Interactions (1 paper). Ann E. Lloyd is often cited by papers focused on Antibiotic Use and Resistance (2 papers), Urinary Tract Infections Management (1 paper) and Parasite Biology and Host Interactions (1 paper). Ann E. Lloyd collaborates with scholars based in United States. Ann E. Lloyd's co-authors include Victoria J. Fraser, Marin H. Kollef, Scott T. Micek, Richard M. Reichley, David J. Ritchie, Michelle Condren, Michael J. Miller, Jeremy L. Johnson, Donald L. Harrison and Gerald F. Fletcher and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Infection and Journal of Evaluation in Clinical Practice.

In The Last Decade

Ann E. Lloyd

7 papers receiving 469 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ann E. Lloyd United States	6	245	218	154	129	120	7	485
Kate Sulham United States	10	252 1.0×	161 0.7×	257 1.7×	73 0.6×	124 1.0×	19	487
Andrea Parisini Italy	9	226 0.9×	162 0.7×	183 1.2×	49 0.4×	69 0.6×	17	419
Nazaret Cobos-Trigueros Spain	14	269 1.1×	180 0.8×	241 1.6×	80 0.6×	192 1.6×	21	617
G. Gallagher United States	4	271 1.1×	131 0.6×	113 0.7×	66 0.5×	62 0.5×	6	410
D. Vanjak France	9	291 1.2×	161 0.7×	194 1.3×	91 0.7×	50 0.4×	14	489
Jacyr Pasternak Brazil	13	218 0.9×	117 0.5×	283 1.8×	100 0.8×	120 1.0×	38	600
C. Natera Spain	8	180 0.7×	138 0.6×	158 1.0×	54 0.4×	147 1.2×	12	390
J.C. Rhee South Korea	8	232 0.9×	126 0.6×	176 1.1×	48 0.4×	71 0.6×	8	562
Soo‐youn Moon South Korea	12	136 0.6×	113 0.5×	169 1.1×	69 0.5×	54 0.5×	28	426
Carmen Paz Oplustil Brazil	9	227 0.9×	109 0.5×	132 0.9×	47 0.4×	49 0.4×	23	377

Countries citing papers authored by Ann E. Lloyd

Since Specialization

Citations

This map shows the geographic impact of Ann E. Lloyd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann E. Lloyd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann E. Lloyd more than expected).

Fields of papers citing papers by Ann E. Lloyd

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann E. Lloyd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann E. Lloyd. The network helps show where Ann E. Lloyd may publish in the future.

Co-authorship network of co-authors of Ann E. Lloyd

This figure shows the co-authorship network connecting the top 25 collaborators of Ann E. Lloyd. A scholar is included among the top collaborators of Ann E. Lloyd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann E. Lloyd. Ann E. Lloyd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Lloyd, Ann E., et al.. (2017). Assessing guideline-concordant prescribing for community-acquired pneumonia. International Journal of Clinical Pharmacy. 39(4). 674–678. 4 indexed citations

2.

Miller, Michael J., et al.. (2017). A literacy-sensitive approach to improving antibiotic understanding in a community-based setting. International Journal of Pharmacy Practice. 25(5). 394–398. 5 indexed citations

3.

Lloyd, Ann E., et al.. (2014). Beyond antibiotic selection: concordance with the IDSA guidelines for uncomplicated urinary tract infections. Infection. 43(1). 89–94. 26 indexed citations

4.

Lloyd, Ann E., et al.. (2014). Treatment Options and Considerations for Intestinal Helminthic Infections. Journal of Pharmacy Technology. 30(4). 130–139. 21 indexed citations

5.

Miller, Michael J., et al.. (2012). Cardiovascular disease and non‐steroidal anti‐inflammatory drug prescribing in the midst of evolving guidelines. Journal of Evaluation in Clinical Practice. 19(6). 1026–1034. 10 indexed citations

6.

Micek, Scott T., Ann E. Lloyd, David J. Ritchie, et al.. (2005). Pseudomonas aeruginosaBloodstream Infection: Importance of Appropriate Initial Antimicrobial Treatment. Antimicrobial Agents and Chemotherapy. 49(4). 1306–1311. 410 indexed citations

7.

Fletcher, Gerald F., et al.. (1988). Exercise testing in patients with musculoskeletal handicaps.. PubMed. 69(2). 123–7. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact